Market Research Logo

Malaysia Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

Concerns over the price of pharmaceuticals will remain a key theme in Malaysia for theforeseeable future. Elevated medicine prices in Malaysia will continue to drive demand for pharmaceuticalprice regulation given the current lack of adequate regulation. The government's proposed legislationhopes to control prices; this will be positive for both the drugmakers and patients, enabling greater accessto medicines.

Headline Expenditure Projections

Pharmaceuticals: MYR8.60bn (USD2.07bn) in 2016 to MYR8.99bn (USD2.12bn) in 2017; +4.5% inlocal currency and 2.0% in US dollar terms. Forecast revised upwards in US dollar terms.

Healthcare: MYR54.65bn (USD13.18bn) in 2016 to MYR59.99bn (USD14.12bn) in 2017; +9.8% inlocal currency and +7.1% in US dollar terms. Forecast revised upwards in US dollar terms.

Risk/Reward Index

Malaysia's growing population and a rising non-communicable disease burden results in the country scoring59.1 out of 100 in BMI's Innovative Pharmaceuticals Risk/Reward Index. While there is an increasedmarket access to new drugs, owing to greater international collaboration and free trade agreements, thefocus on cost-efficiency within the healthcare sector will limit the market's growth potential.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Malaysia 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Malaysia 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Malaysia 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Malaysia 2013-2021)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Malaysia 2013-2021)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Malaysia 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Malaysia 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Malaysia 2015-2021)
Industry Risk/Reward Index
Asia Pacific Pharmaceuticals: Diverse Opportunities And Inherent Risks
Malaysia Risk/Reward Index - Q4 2017
Reward
Risk
Regulatory Review
Intellectual Property Issues
Pricing Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Malaysia 2011-2016)
Table: Healthcare Personnel (Malaysia 2011-2016)
Table: Healthcare Activity (Malaysia 2011-2016)
Healthcare Insurance
Table: Main Features Of 1Care
Medical Tourism
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Culture-Specific Medicines
Pharmaceutical Distribution
Table: Drug Wholesalers & Importers, 2002-2010
Pharmaceutical Retail Sector
Company Profile
Chemical Company Of Malaysia
Kotra Pharma
Novartis
Ranbaxy Malaysia
Sanofi
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Malaysia 1990-2025)
Table: Key Population Ratios (Malaysia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Malaysia 1990-2025)
Table: Population By Age Group (Malaysia 1990-2025)
Table: Population By Age Group % (Malaysia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report